Go Pro
→ Trump's New Dollar (From Porter & Company) (Ad)tc pixel Free HQH Stock Alerts

abrdn Healthcare Investors (HQH) Competitors

abrdn Healthcare Investors logo
$24.35 +0.51 (+2.14%)
As of 08/21/2026 03:58 PM Eastern
Compare

HQH vs. BGC, OTF, MC, MRX, and LAZ

Should you buy abrdn Healthcare Investors stock or one of its competitors? abrdn Healthcare Investors's main competitors and comparable companies include BGC Group (BGC), Blue Owl Technology Finance (OTF), Moelis & Company (MC), Marex Group plc Ordinary Shares (MRX), and Lazard (LAZ). Companies are selected based on similarities in market, industry, and size. These companies are all part of the "capital markets" industry.

How does abrdn Healthcare Investors compare to BGC Group?

BGC Group (NASDAQ:BGC) and abrdn Healthcare Investors (NYSE:HQH) are both finance companies, but which is the better business? We will contrast the two businesses based on the strength of their risk, media sentiment, dividends, profitability, analyst recommendations, valuation, earnings and institutional ownership.

BGC Group has higher revenue and earnings than abrdn Healthcare Investors.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
BGC Group$2.94B1.92$154.96M$0.4128.90
abrdn Healthcare InvestorsN/AN/AN/AN/AN/A

BGC Group has a beta of 0.95, suggesting that its share price is 5% less volatile than the broader market. Comparatively, abrdn Healthcare Investors has a beta of 0.78, suggesting that its share price is 22% less volatile than the broader market.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
BGC Group
0 Sell rating(s)
1 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
2.00
abrdn Healthcare Investors
0 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
0.00

52.1% of BGC Group shares are owned by institutional investors. Comparatively, 32.6% of abrdn Healthcare Investors shares are owned by institutional investors. 2.4% of BGC Group shares are owned by company insiders. Comparatively, 7.3% of abrdn Healthcare Investors shares are owned by company insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a company is poised for long-term growth.

BGC Group has a net margin of 6.04% compared to abrdn Healthcare Investors' net margin of 0.00%. BGC Group's return on equity of 54.86% beat abrdn Healthcare Investors' return on equity.

Company Net Margins Return on Equity Return on Assets
BGC Group6.04% 54.86% 12.14%
abrdn Healthcare Investors N/A N/A N/A

In the previous week, abrdn Healthcare Investors had 1 more articles in the media than BGC Group. MarketBeat recorded 2 mentions for abrdn Healthcare Investors and 1 mentions for BGC Group. BGC Group's average media sentiment score of 1.29 beat abrdn Healthcare Investors' score of 1.01 indicating that BGC Group is being referred to more favorably in the media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
BGC Group
1 Very Positive mention(s)
0 Positive mention(s)
0 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive
abrdn Healthcare Investors
1 Very Positive mention(s)
1 Positive mention(s)
0 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive

BGC Group pays an annual dividend of $0.08 per share and has a dividend yield of 0.7%. abrdn Healthcare Investors pays an annual dividend of $2.32 per share and has a dividend yield of 9.5%. BGC Group pays out 19.5% of its earnings in the form of a dividend. BGC Group has raised its dividend for 1 consecutive years.

Summary

BGC Group beats abrdn Healthcare Investors on 9 of the 13 factors compared between the two stocks.

How does abrdn Healthcare Investors compare to Blue Owl Technology Finance?

Blue Owl Technology Finance (NYSE:OTF) and abrdn Healthcare Investors (NYSE:HQH) are both finance companies, but which is the better business? We will contrast the two companies based on the strength of their institutional ownership, media sentiment, dividends, profitability, earnings, analyst recommendations, risk and valuation.

In the previous week, Blue Owl Technology Finance had 6 more articles in the media than abrdn Healthcare Investors. MarketBeat recorded 8 mentions for Blue Owl Technology Finance and 2 mentions for abrdn Healthcare Investors. abrdn Healthcare Investors' average media sentiment score of 1.01 beat Blue Owl Technology Finance's score of 0.12 indicating that abrdn Healthcare Investors is being referred to more favorably in the news media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Blue Owl Technology Finance
1 Very Positive mention(s)
1 Positive mention(s)
4 Neutral mention(s)
0 Negative mention(s)
1 Very Negative mention(s)
Neutral
abrdn Healthcare Investors
1 Very Positive mention(s)
1 Positive mention(s)
0 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive

32.6% of abrdn Healthcare Investors shares are held by institutional investors. 0.1% of Blue Owl Technology Finance shares are held by company insiders. Comparatively, 7.3% of abrdn Healthcare Investors shares are held by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company is poised for long-term growth.

Blue Owl Technology Finance pays an annual dividend of $1.40 per share and has a dividend yield of 12.8%. abrdn Healthcare Investors pays an annual dividend of $2.32 per share and has a dividend yield of 9.5%. Blue Owl Technology Finance pays out 175.0% of its earnings in the form of a dividend, suggesting it may not have sufficient earnings to cover its dividend payment in the future.

Blue Owl Technology Finance has higher revenue and earnings than abrdn Healthcare Investors.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Blue Owl Technology Finance$437.92M11.47$720.37M$0.8013.70
abrdn Healthcare InvestorsN/AN/AN/AN/AN/A

Blue Owl Technology Finance has a beta of -0.86, suggesting that its stock price is 186% less volatile than the broader market. Comparatively, abrdn Healthcare Investors has a beta of 0.78, suggesting that its stock price is 22% less volatile than the broader market.

Blue Owl Technology Finance presently has a consensus target price of $13.60, suggesting a potential upside of 24.09%. Given Blue Owl Technology Finance's stronger consensus rating and higher possible upside, research analysts clearly believe Blue Owl Technology Finance is more favorable than abrdn Healthcare Investors.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Blue Owl Technology Finance
0 Sell rating(s)
3 Hold rating(s)
4 Buy rating(s)
0 Strong Buy rating(s)
2.57
abrdn Healthcare Investors
0 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
0.00

Blue Owl Technology Finance has a net margin of 28.69% compared to abrdn Healthcare Investors' net margin of 0.00%. Blue Owl Technology Finance's return on equity of 7.17% beat abrdn Healthcare Investors' return on equity.

Company Net Margins Return on Equity Return on Assets
Blue Owl Technology Finance28.69% 7.17% 3.86%
abrdn Healthcare Investors N/A N/A N/A

Summary

Blue Owl Technology Finance beats abrdn Healthcare Investors on 9 of the 14 factors compared between the two stocks.

How does abrdn Healthcare Investors compare to Moelis & Company?

Moelis & Company (NYSE:MC) and abrdn Healthcare Investors (NYSE:HQH) are both finance companies, but which is the better business? We will compare the two companies based on the strength of their analyst recommendations, risk, earnings, profitability, dividends, valuation, institutional ownership and media sentiment.

Moelis & Company has a net margin of 14.50% compared to abrdn Healthcare Investors' net margin of 0.00%. Moelis & Company's return on equity of 39.59% beat abrdn Healthcare Investors' return on equity.

Company Net Margins Return on Equity Return on Assets
Moelis & Company14.50% 39.59% 17.04%
abrdn Healthcare Investors N/A N/A N/A

In the previous week, Moelis & Company had 15 more articles in the media than abrdn Healthcare Investors. MarketBeat recorded 17 mentions for Moelis & Company and 2 mentions for abrdn Healthcare Investors. abrdn Healthcare Investors' average media sentiment score of 1.01 beat Moelis & Company's score of 0.29 indicating that abrdn Healthcare Investors is being referred to more favorably in the news media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Moelis & Company
3 Very Positive mention(s)
1 Positive mention(s)
2 Neutral mention(s)
1 Negative mention(s)
0 Very Negative mention(s)
Neutral
abrdn Healthcare Investors
1 Very Positive mention(s)
1 Positive mention(s)
0 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive

Moelis & Company has higher revenue and earnings than abrdn Healthcare Investors.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Moelis & Company$1.52B3.52$233.04M$2.8723.77
abrdn Healthcare InvestorsN/AN/AN/AN/AN/A

91.5% of Moelis & Company shares are held by institutional investors. Comparatively, 32.6% of abrdn Healthcare Investors shares are held by institutional investors. 6.3% of Moelis & Company shares are held by insiders. Comparatively, 7.3% of abrdn Healthcare Investors shares are held by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a company will outperform the market over the long term.

Moelis & Company pays an annual dividend of $2.60 per share and has a dividend yield of 3.8%. abrdn Healthcare Investors pays an annual dividend of $2.32 per share and has a dividend yield of 9.5%. Moelis & Company pays out 90.6% of its earnings in the form of a dividend, suggesting it may not have sufficient earnings to cover its dividend payment in the future. Moelis & Company has increased its dividend for 1 consecutive years.

Moelis & Company currently has a consensus target price of $73.63, indicating a potential upside of 7.94%. Given Moelis & Company's stronger consensus rating and higher possible upside, equities research analysts plainly believe Moelis & Company is more favorable than abrdn Healthcare Investors.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Moelis & Company
1 Sell rating(s)
7 Hold rating(s)
2 Buy rating(s)
0 Strong Buy rating(s)
2.10
abrdn Healthcare Investors
0 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
0.00

Moelis & Company has a beta of 1.84, indicating that its share price is 84% more volatile than the broader market. Comparatively, abrdn Healthcare Investors has a beta of 0.78, indicating that its share price is 22% less volatile than the broader market.

Summary

Moelis & Company beats abrdn Healthcare Investors on 11 of the 15 factors compared between the two stocks.

How does abrdn Healthcare Investors compare to Marex Group plc Ordinary Shares?

Marex Group plc Ordinary Shares (NASDAQ:MRX) and abrdn Healthcare Investors (NYSE:HQH) are both finance companies, but which is the better business? We will contrast the two companies based on the strength of their analyst recommendations, earnings, risk, valuation, profitability, media sentiment, institutional ownership and dividends.

Marex Group plc Ordinary Shares has higher revenue and earnings than abrdn Healthcare Investors.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Marex Group plc Ordinary Shares$2.02B2.63$307.20M$5.5713.10
abrdn Healthcare InvestorsN/AN/AN/AN/AN/A

32.6% of abrdn Healthcare Investors shares are owned by institutional investors. 3.8% of Marex Group plc Ordinary Shares shares are owned by insiders. Comparatively, 7.3% of abrdn Healthcare Investors shares are owned by insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a stock will outperform the market over the long term.

Marex Group plc Ordinary Shares has a beta of -0.1, suggesting that its share price is 110% less volatile than the broader market. Comparatively, abrdn Healthcare Investors has a beta of 0.78, suggesting that its share price is 22% less volatile than the broader market.

In the previous week, Marex Group plc Ordinary Shares had 4 more articles in the media than abrdn Healthcare Investors. MarketBeat recorded 6 mentions for Marex Group plc Ordinary Shares and 2 mentions for abrdn Healthcare Investors. Marex Group plc Ordinary Shares' average media sentiment score of 1.54 beat abrdn Healthcare Investors' score of 1.01 indicating that Marex Group plc Ordinary Shares is being referred to more favorably in the media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Marex Group plc Ordinary Shares
6 Very Positive mention(s)
0 Positive mention(s)
0 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Very Positive
abrdn Healthcare Investors
1 Very Positive mention(s)
1 Positive mention(s)
0 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive

Marex Group plc Ordinary Shares has a net margin of 17.43% compared to abrdn Healthcare Investors' net margin of 0.00%. Marex Group plc Ordinary Shares' return on equity of 27.94% beat abrdn Healthcare Investors' return on equity.

Company Net Margins Return on Equity Return on Assets
Marex Group plc Ordinary Shares17.43% 27.94% 1.08%
abrdn Healthcare Investors N/A N/A N/A

Marex Group plc Ordinary Shares currently has a consensus price target of $82.00, indicating a potential upside of 12.34%. Given Marex Group plc Ordinary Shares' stronger consensus rating and higher probable upside, analysts plainly believe Marex Group plc Ordinary Shares is more favorable than abrdn Healthcare Investors.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Marex Group plc Ordinary Shares
0 Sell rating(s)
1 Hold rating(s)
7 Buy rating(s)
1 Strong Buy rating(s)
3.00
abrdn Healthcare Investors
0 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
0.00

Marex Group plc Ordinary Shares pays an annual dividend of $0.64 per share and has a dividend yield of 0.9%. abrdn Healthcare Investors pays an annual dividend of $2.32 per share and has a dividend yield of 9.5%. Marex Group plc Ordinary Shares pays out 11.5% of its earnings in the form of a dividend.

Summary

Marex Group plc Ordinary Shares beats abrdn Healthcare Investors on 10 of the 15 factors compared between the two stocks.

How does abrdn Healthcare Investors compare to Lazard?

Lazard (NYSE:LAZ) and abrdn Healthcare Investors (NYSE:HQH) are both finance companies, but which is the superior stock? We will contrast the two companies based on the strength of their analyst recommendations, risk, earnings, media sentiment, profitability, dividends, valuation and institutional ownership.

54.8% of Lazard shares are held by institutional investors. Comparatively, 32.6% of abrdn Healthcare Investors shares are held by institutional investors. 1.0% of Lazard shares are held by insiders. Comparatively, 7.3% of abrdn Healthcare Investors shares are held by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock is poised for long-term growth.

Lazard pays an annual dividend of $2.00 per share and has a dividend yield of 4.5%. abrdn Healthcare Investors pays an annual dividend of $2.32 per share and has a dividend yield of 9.5%. Lazard pays out 98.0% of its earnings in the form of a dividend, suggesting it may not have sufficient earnings to cover its dividend payment in the future.

Lazard has a beta of 1.43, suggesting that its share price is 43% more volatile than the broader market. Comparatively, abrdn Healthcare Investors has a beta of 0.78, suggesting that its share price is 22% less volatile than the broader market.

Lazard has higher revenue and earnings than abrdn Healthcare Investors.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Lazard$3.10B1.57$236.83M$2.0421.64
abrdn Healthcare InvestorsN/AN/AN/AN/AN/A

In the previous week, Lazard had 9 more articles in the media than abrdn Healthcare Investors. MarketBeat recorded 11 mentions for Lazard and 2 mentions for abrdn Healthcare Investors. abrdn Healthcare Investors' average media sentiment score of 1.01 beat Lazard's score of 0.51 indicating that abrdn Healthcare Investors is being referred to more favorably in the news media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Lazard
3 Very Positive mention(s)
2 Positive mention(s)
5 Neutral mention(s)
1 Negative mention(s)
0 Very Negative mention(s)
Positive
abrdn Healthcare Investors
1 Very Positive mention(s)
1 Positive mention(s)
0 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive

Lazard has a net margin of 6.95% compared to abrdn Healthcare Investors' net margin of 0.00%. Lazard's return on equity of 23.58% beat abrdn Healthcare Investors' return on equity.

Company Net Margins Return on Equity Return on Assets
Lazard6.95% 23.58% 4.63%
abrdn Healthcare Investors N/A N/A N/A

Lazard presently has a consensus target price of $50.38, indicating a potential upside of 14.13%. Given Lazard's stronger consensus rating and higher probable upside, equities analysts clearly believe Lazard is more favorable than abrdn Healthcare Investors.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Lazard
3 Sell rating(s)
4 Hold rating(s)
4 Buy rating(s)
0 Strong Buy rating(s)
2.09
abrdn Healthcare Investors
0 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
0.00

Summary

Lazard beats abrdn Healthcare Investors on 10 of the 14 factors compared between the two stocks.

Get abrdn Healthcare Investors News Delivered to You Automatically

Sign up to receive the latest news and ratings for HQH and its competitors with MarketBeat's FREE daily newsletter.

Subscribe Now
SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding HQH and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NYSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

HQH vs. The Competition

Export
Metricabrdn Healthcare InvestorsCapital Markets IndustryFinance SectorNYSE Exchange
Market Cap$1.39B$5.66B$13.63B$24.30B
Dividend Yield9.51%7.38%5.89%3.70%
P/E RatioN/A39.0929.6130.31
Price / SalesN/A1,235.25516.5719.89
Price / CashN/A48.3138.1932.49
Price / BookN/A2.132.186.77
Net IncomeN/A$416.48M$1.31B$1.07B
7 Day Performance4.24%-0.25%-0.30%-0.65%
1 Month Performance15.21%2.06%2.37%3.38%
1 Year Performance48.54%5.71%9.68%14.90%

abrdn Healthcare Investors Competitors List

Export
CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
HQH
abrdn Healthcare Investors
N/A$24.35
+2.1%		N/A+48.5%$1.39BN/AN/A147,000
BGC
BGC Group
3.4172 of 5 stars		$11.07
-0.8%		N/A+16.9%$5.33B$2.94B27.004,560
OTF
Blue Owl Technology Finance
4.777 of 5 stars		$11.13
0.0%		$13.60
+22.2%		N/A$5.25B$1.15B13.91N/A
MC
Moelis & Company
4.1741 of 5 stars		$66.46
-0.4%		$73.63
+10.8%		-6.0%$5.22B$1.57B23.161,416
MRX
Marex Group plc Ordinary Shares
4.5187 of 5 stars		$71.88
+0.6%		$82.00
+14.1%		N/A$5.18B$2.02B12.903,109

Related Companies and Tools

Related Companies
Top 10 Stock Comparisons

This page (NYSE:HQH) was last updated on 8/23/2026 by MarketBeat.com Staff.
From Our Partners
ALERT: Drop these 5 stocks before the market opens tomorrow!
The Wall Street Journal is already raising the alarm about a potential market crash, and Weiss Ratings researc...
Weiss Ratings | Sponsoredtc pixel
Louis Navellier: My #1 AI stock for 2026 (name & ticker inside)
Louis Navellier's Stock Grader system helped him flag Nvidia before its 82,000% run and has identified the top...
InvestorPlace | Sponsoredtc pixel
Ready to give options a try? Your first trade (Ticker included) -INSIDE
Tired of trying tactic after tactic when it comes to options trades... only to be met with market noise and st...
Base Camp Trading | Sponsoredtc pixel
Trump Takes Emergency Action - Plus Elon Musk's New Venture
Elon Musk has quietly launched a new venture - one that has nothing to do with rockets, EVs, or Neuralink. Tru...
Altimetry | Sponsoredtc pixel
Iran War Shock: What I Was Told In That Private Meeting
You’re Being LIED To About The Iran War Forget EVERYTHING you’ve heard about the Iran war. Especially th...
Banyan Hill Publishing | Sponsoredtc pixel
My top 3 AI picks for the next decade
Alexander Green bought Apple in 1996, recommended Nvidia at a split-adjusted 66 cents in 2004, and picked up A...
The Oxford Club | Sponsoredtc pixel
Buy this stock today
Marc Chaikin, founder of Chaikin Analytics, is sharing a strategy he calls 'Sell This, Buy That' - a way to mo...
Chaikin Analytics | Sponsoredtc pixel
Here’s the stock symbol I’ve promised
Whitney Tilson of Stansberry Research has long recommended Berkshire Hathaway as a core retirement holding - b...
Stansberry Research | Sponsoredtc pixel